 | • レポートコード：QYR2104Z6005 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、減量治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（食欲抑制、体代謝増加、消化吸収パターン妨害）、用途別市場規模（病院、専門クリニック、小売薬局、通信販売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・減量治療薬の市場動向 ・企業の競争状況、市場シェア ・減量治療薬の種類別市場規模（食欲抑制、体代謝増加、消化吸収パターン妨害） ・減量治療薬の用途別市場規模（病院、専門クリニック、小売薬局、通信販売薬局、その他） ・減量治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・減量治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・減量治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・減量治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・減量治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Sanofi、Novo Nordisk、Arena Pharmaceuticals、Orexigen Therapeutics、Johnson & Johnson、Pfizer、Novartis AG、Biocon、VIVUS、Eli Lilly、Amgen、Zafgen、Roche、Eisai） ・結論 |
Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
Market Analysis and Insights: Global Weight Loss Therapeutics Market
The global Weight Loss Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Weight Loss Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Weight Loss Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Weight Loss Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Weight Loss Therapeutics market.
Global Weight Loss Therapeutics Scope and Market Size
Weight Loss Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Weight Loss Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Segment by Application
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
Arena Pharmaceuticals
Orexigen Therapeutics
Amgen
Zafgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Appetite Suppression
1.2.3 Increasing Body Metabolism
1.2.4 Interfering with the Digestion Absorption Patterns
1.3 Market by Application
1.3.1 Global Weight Loss Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Retail Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Weight Loss Therapeutics Market Perspective (2016-2027)
2.2 Weight Loss Therapeutics Growth Trends by Regions
2.2.1 Weight Loss Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Weight Loss Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Weight Loss Therapeutics Industry Dynamic
2.3.1 Weight Loss Therapeutics Market Trends
2.3.2 Weight Loss Therapeutics Market Drivers
2.3.3 Weight Loss Therapeutics Market Challenges
2.3.4 Weight Loss Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Weight Loss Therapeutics Players by Revenue
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
3.4 Global Weight Loss Therapeutics Market Concentration Ratio
3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2020
3.5 Weight Loss Therapeutics Key Players Head office and Area Served
3.6 Key Players Weight Loss Therapeutics Product Solution and Service
3.7 Date of Enter into Weight Loss Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Weight Loss Therapeutics Breakdown Data by Type
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027)
5 Weight Loss Therapeutics Breakdown Data by Application
5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Weight Loss Therapeutics Market Size (2016-2027)
6.2 North America Weight Loss Therapeutics Market Size by Type
6.2.1 North America Weight Loss Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Weight Loss Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Weight Loss Therapeutics Market Size by Type (2016-2027)
6.3 North America Weight Loss Therapeutics Market Size by Application
6.3.1 North America Weight Loss Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Weight Loss Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Weight Loss Therapeutics Market Size by Application (2016-2027)
6.4 North America Weight Loss Therapeutics Market Size by Country
6.4.1 North America Weight Loss Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Weight Loss Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Weight Loss Therapeutics Market Size (2016-2027)
7.2 Europe Weight Loss Therapeutics Market Size by Type
7.2.1 Europe Weight Loss Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Weight Loss Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Weight Loss Therapeutics Market Size by Type (2016-2027)
7.3 Europe Weight Loss Therapeutics Market Size by Application
7.3.1 Europe Weight Loss Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Weight Loss Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Weight Loss Therapeutics Market Size by Application (2016-2027)
7.4 Europe Weight Loss Therapeutics Market Size by Country
7.4.1 Europe Weight Loss Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Weight Loss Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type
8.2.1 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application
8.3.1 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Weight Loss Therapeutics Market Size by Region
8.4.1 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Weight Loss Therapeutics Market Size (2016-2027)
9.2 Latin America Weight Loss Therapeutics Market Size by Type
9.2.1 Latin America Weight Loss Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Weight Loss Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Weight Loss Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Weight Loss Therapeutics Market Size by Application
9.3.1 Latin America Weight Loss Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Weight Loss Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Weight Loss Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Weight Loss Therapeutics Market Size by Country
9.4.1 Latin America Weight Loss Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Weight Loss Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type
10.2.1 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application
10.3.1 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Weight Loss Therapeutics Market Size by Country
10.4.1 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Weight Loss Therapeutics Introduction
11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Weight Loss Therapeutics Introduction
11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Details
11.4.2 Arena Pharmaceuticals Business Overview
11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021)
11.4.5 Arena Pharmaceuticals Recent Development
11.5 Orexigen Therapeutics
11.5.1 Orexigen Therapeutics Company Details
11.5.2 Orexigen Therapeutics Business Overview
11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021)
11.5.5 Orexigen Therapeutics Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Weight Loss Therapeutics Introduction
11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Weight Loss Therapeutics Introduction
11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021)
11.8.5 Novartis AG Recent Development
11.9 Biocon
11.9.1 Biocon Company Details
11.9.2 Biocon Business Overview
11.9.3 Biocon Weight Loss Therapeutics Introduction
11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2016-2021)
11.9.5 Biocon Recent Development
11.10 VIVUS
11.10.1 VIVUS Company Details
11.10.2 VIVUS Business Overview
11.10.3 VIVUS Weight Loss Therapeutics Introduction
11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021)
11.10.5 VIVUS Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021)
11.11.5 Eli Lilly Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Weight Loss Therapeutics Introduction
11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 Zafgen
11.13.1 Zafgen Company Details
11.13.2 Zafgen Business Overview
11.13.3 Zafgen Weight Loss Therapeutics Introduction
11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021)
11.13.5 Zafgen Recent Development
11.14 Roche
11.14.1 Roche Company Details
11.14.2 Roche Business Overview
11.14.3 Roche Weight Loss Therapeutics Introduction
11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2016-2021)
11.14.5 Roche Recent Development
11.15 Eisai
11.15.1 Eisai Company Details
11.15.2 Eisai Business Overview
11.15.3 Eisai Weight Loss Therapeutics Introduction
11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2016-2021)
11.15.5 Eisai Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Appetite Suppression
Table 3. Key Players of Increasing Body Metabolism
Table 4. Key Players of Interfering with the Digestion Absorption Patterns
Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Weight Loss Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Weight Loss Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Weight Loss Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Weight Loss Therapeutics Market Share by Regions (2022-2027)
Table 11. Weight Loss Therapeutics Market Trends
Table 12. Weight Loss Therapeutics Market Drivers
Table 13. Weight Loss Therapeutics Market Challenges
Table 14. Weight Loss Therapeutics Market Restraints
Table 15. Global Weight Loss Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020)
Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Weight Loss Therapeutics Product Solution and Service
Table 22. Date of Enter into Weight Loss Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Weight Loss Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Weight Loss Therapeutics Product
Table 65. Abbott Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Weight Loss Therapeutics Product
Table 70. Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Weight Loss Therapeutics Product
Table 75. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. Arena Pharmaceuticals Company Details
Table 78. Arena Pharmaceuticals Business Overview
Table 79. Arena Pharmaceuticals Weight Loss Therapeutics Product
Table 80. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Arena Pharmaceuticals Recent Development
Table 82. Orexigen Therapeutics Company Details
Table 83. Orexigen Therapeutics Business Overview
Table 84. Orexigen Therapeutics Weight Loss Therapeutics Product
Table 85. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Orexigen Therapeutics Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Weight Loss Therapeutics Product
Table 90. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Weight Loss Therapeutics Product
Table 95. Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Novartis AG Company Details
Table 98. Novartis AG Business Overview
Table 99. Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. Biocon Company Details
Table 102. Biocon Business Overview
Table 103. Biocon Weight Loss Therapeutics Product
Table 104. Biocon Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Biocon Recent Development
Table 106. VIVUS Company Details
Table 107. VIVUS Business Overview
Table 108. VIVUS Weight Loss Therapeutics Product
Table 109. VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 110. VIVUS Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Weight Loss Therapeutics Product
Table 114. Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. Amgen Company Details
Table 117. Amgen Business Overview
Table 118. Amgen Weight Loss Therapeutics Product
Table 119. Amgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Amgen Recent Development
Table 121. Zafgen Company Details
Table 122. Zafgen Business Overview
Table 123. Zafgen Weight Loss Therapeutics Product
Table 124. Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Zafgen Recent Development
Table 126. Roche Company Details
Table 127. Roche Business Overview
Table 128. Roche Weight Loss Therapeutics Product
Table 129. Roche Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 130. Roche Recent Development
Table 131. Eisai Company Details
Table 132. Eisai Business Overview
Table 133. Eisai Weight Loss Therapeutics Product
Table 134. Eisai Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
Table 135. Eisai Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Appetite Suppression Features
Figure 3. Increasing Body Metabolism Features
Figure 4. Interfering with the Digestion Absorption Patterns Features
Figure 5. Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Weight Loss Therapeutics Report Years Considered
Figure 12. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Weight Loss Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Weight Loss Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Weight Loss Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Weight Loss Therapeutics Market Share by Players in 2020
Figure 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2020
Figure 19. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Weight Loss Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Weight Loss Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Weight Loss Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Weight Loss Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Weight Loss Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Weight Loss Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Weight Loss Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Weight Loss Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2016-2027)
Figure 41. China Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Weight Loss Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Weight Loss Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Weight Loss Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Weight Loss Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Weight Loss Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 64. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 68. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 69. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 70. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 71. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 72. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 73. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 74. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の減量・体重管理市場 2021：企業別、地域別、種類・用途別 The Weight Loss and Weight Management market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 世界の減量・体重管理ダイエット市場 2021：企業別、地域別、種類・用途別 The Weight Loss and Weight Management Diets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の減量・体重管理用製品市場 2021：企業別、地域別、種類・用途別 The Weight Loss and Weight Management Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の減量サプリメント市場 2021：企業別、地域別、種類・用途別 The Weight Loss Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…